Vivace Therapeutics has closed $35m in a Series D financing round to support the clinical development of its cancer drug ...

Mesothelioma is a cancer that develops in the thin tissue that lines some internal organs. It most frequently develops in the pleura, the tissue lining the chest cavity and lungs. It can also form ...

DelveInsight’s, “Mesothelioma Pipeline Insight 2025” report provides comprehensive insights about 45+ companies and 50+ ...

According to the Center for Disease Control and Prevention (CDC), cancer is the second-leading cause of death in the United ...

For nearly 20 years, mesothelioma treatment options were limited to a single regimen: pemetrexed with a platinum agent. Now, there are 3 systemic treatment options available. In this video, Hedy Lee ...

Nobody likes to talk or think about cancer, but it’s a serious disease that we should all aim to understand a little better. Better understanding the signs and symptoms of […] ...

Updated ASCO guidelines for pleural mesothelioma refine surgery use, recommend immunotherapy, genetic testing, and improve ...

In Cappadocia, Turkey, an unprecedented mesothelioma epidemic causes 50% of all deaths in three small villages. Initially linked solely to the exposure to a fibrous mineral, erionite, recent ...

Vivace Therapeutics Inc. closed a $35 million series D round led by RA Capital Management, an existing investor, and including other backers already on board: Canaan Partners and Cenova Capital.

At the start of the Industrial Revolution in the early 1900s, asbestos was a material of choice for building heat-resistant insulation, fireproofing construction materials, and pipe coverings. The ind ...